Phibro Animal Health Corporation (NASDAQ:PAHC) Files An 8-K Other EventsITEM 8.01 OTHER EVENTS
On July 24, 2017, Phibro Animal Health Corporation issued a press release announcing the declaration of a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on September 27, 2017, to stockholders of record at the close of business on September 6, 2017. A copy of the press release announcing the dividend is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
|
Exhibit Number |
Description |
| 99.1 | Press Release, dated July 24, 2017. |
PHIBRO ANIMAL HEALTH CORP ExhibitEX-99.1 2 v471337_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK,…To view the full exhibit click here
About Phibro Animal Health Corporation (NASDAQ:PAHC)
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products. The Company also manufactures and markets specific ingredients for use in the personal care, automotive, industrial chemical and chemical catalyst industries. The Company’s Medicated Feed Additives (MFAs) and other business consist of concentrated medicated products, which are administered through animal feeds. The Company’s MFAs and other business consists of the production and sale of antibacterials, including Stafac, Terramycin, Neo-Terramycin and Mecadox and anticoccidials, including Nicarb, Aviax, Aviax Plus, Coxistac and amprolium.